Cargando…

Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China

OBJECTIVE: This survey aims to explore the current medical treatment of major depressive disorder (MDD) in China and match its degree with Canadian Network for Mood and Anxiety Treatments (CANMAT). METHODS: A total of 3275 patients were recruited from 16 mental health centers and 16 general hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yuncheng, Wu, Zhiguo, Zhao, Dongmei, Wu, Xiaohui, He, Ruoqiao, Wang, Zuowei, Peng, Daihui, Fang, Yiru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106790/ https://www.ncbi.nlm.nih.gov/pubmed/37077710 http://dx.doi.org/10.2147/NDT.S401359

Ejemplares similares

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China
por: Yang, Lu, et al.
Publicado: (2022)

Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis
por: Wu, Xiaohui, et al.
Publicado: (2022)

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder
por: Zhu, Yuncheng, et al.
Publicado: (2022)

Guidelines Disconcordance in Acute Bipolar Depression: Data from the National Bipolar Mania Pathway Survey (BIPAS) in Mainland China
por: Wang, Zuowei, et al.
Publicado: (2014)

Association between olfactory function and inhibition of emotional competing distractors in major depressive disorder
por: Wang, Fang, et al.
Publicado: (2020)

Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
por: Xia, Weiping, et al.
Publicado: (2018)

Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China
por: Wang, Zuowei, et al.
Publicado: (2014)

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
por: Yatham, Lakshmi N, et al.
Publicado: (2018)

Identification of IL6 as a susceptibility gene for major depressive disorder
por: Zhang, Chen, et al.
Publicado: (2016)

Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression
por: Hu, Guoqin, et al.
Publicado: (2021)

Evaluation of antidepressant polypharmacy and other interventions for treatment-resistant depression
por: PENG, Daihui, et al.
Publicado: (2014)

Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder
por: Yi, Zhenghui, et al.
Publicado: (2012)

Correction: Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Effects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder
por: Zhou, Rubai, et al.
Publicado: (2018)

Probing the clinical and brain structural boundaries of bipolar and major depressive disorder
por: Yang, Tao, et al.
Publicado: (2021)

Comorbidity of depressive and anxiety disorders: challenges in diagnosis and assessment
por: WU, Zhiguo, et al.
Publicado: (2014)

P300 event-related potentials in patients with different subtypes of depressive disorders
por: Wang, Yun, et al.
Publicado: (2023)

The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
por: Liu, Hongye, et al.
Publicado: (2018)

Are subsyndromal symptomatic depression and major depressive disorder distinct disorders?
por: Yi, Zhenghui, et al.
Publicado: (2012)

Epigenetic differences in monozygotic twins discordant for major depressive disorder
por: Malki, K, et al.
Publicado: (2016)

Does the Ranking Matter? A Retrospective Cohort Study Investigating the Impact of the 2018 CANMAT and ISBD Guidelines for the Management of Patients with Bipolar Disorder Treatment Recommendations for Acute Mania on Rehospitalization Rates
por: Gomes, Fabiano A., et al.
Publicado: (2023)

Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder
por: Yang, Chengqing, et al.
Publicado: (2017)

The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
por: Liu, Xiaohua, et al.
Publicado: (2020)

Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder
por: Tastevin, Maud, et al.
Publicado: (2020)

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
por: Li, Zezhi, et al.
Publicado: (2021)

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial
por: Yatham, L N, et al.
Publicado: (2016)

Response Inhibition and Emotional Regulation in the Patients with Attention-Deficit/Hyperactivity Disorder and Comorbidity of Disruptive, Impulse-Control, and Conduct Disorders
por: Jiang, Xixi, et al.
Publicado: (2019)

Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis
por: Yao, Liang, et al.
Publicado: (2021)

Potential mechanisms of non-suicidal self-injury (NSSI) in major depressive disorder: a systematic review
por: Wu, Baichuan, et al.
Publicado: (2023)

COVID‐19 and post‐traumatic stress disorder: A vicious circle involving immunosuppression
por: Liang, Xiao, et al.
Publicado: (2020)

Lower Health Literacy of Mania Than Depression Among Older People: A Random Survey of a Community Healthcare Service Center
por: Huang, Leping, et al.
Publicado: (2021)

Major Depressive Disorder, Suicidal Thoughts and Behaviors, and Cannabis involvement in Discordant Twins: a Retrospective Cohort Study
por: Agrawal, Arpana, et al.
Publicado: (2017)

A Preliminary Study of Different Treatment Strategies for Anxious Depression
por: Wang, Yun, et al.
Publicado: (2022)

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang, Yun, et al.
Publicado: (2021)

Gene expression profiling in peripheral blood lymphocytes for major depression: preliminary cues from Chinese discordant sib-pair study
por: Wu, Chan, et al.
Publicado: (2021)

Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis
por: Wang, Zuowei, et al.
Publicado: (2014)

TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
por: Liu, Hongmei, et al.
Publicado: (2022)

Correction to: Gene expression profiling in peripheral blood lymphocytes for major depression: preliminary cues from Chinese discordant sib-pair study
por: Wu, Chan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3f8r6rv3i9ov0bqtbd42olusmv